Management of multiple sclerosis in older adults: review of current evidence and future perspectives

Kimberly A DiMauro1, Carol Swetlik1, Jeffrey A Cohen2

  • 1Mellen Center for MS Treatment and Research, Cleveland Clinic, Neurological Institute, Cleveland, OH, USA.

Journal of Neurology
|April 30, 2024
PubMed
Abstract

Insights

Older adults with multiple sclerosis (MS) require specialized care due to unique health needs. This review addresses knowledge gaps in managing aging MS patients, focusing on demographics, disease progression, and treatment strategies.

Area of Science:

  • Neurology
  • Geriatrics
  • Immunology

Background:

  • The global prevalence of multiple sclerosis (MS) and its aging patient population is rising.
  • Older adults with MS (OAMS) are an underrepresented demographic in current medical literature.
  • Understanding the unique needs of OAMS is crucial for effective management.

Purpose of the Study:

  • To examine the evolving demographics, disease course, and treatment considerations for OAMS.
  • To identify and address critical knowledge gaps in the management of OAMS.
  • To inform clinical practice and guide future research for OAMS.

Main Methods:

  • This narrative review synthesizes existing literature on OAMS.
  • It analyzes demographic trends, disease progression patterns, and therapeutic interventions.
  • Key areas of focus include comorbidities, immune system changes, and neurodegeneration in OAMS.

Main Results:

  • OAMS present distinct clinical challenges compared to younger MS patients.
  • Factors such as comorbidities, aging immune system, and reduced neurological reserve necessitate tailored care.
  • The benefit-risk profile of disease-modifying therapies (DMTs) requires careful evaluation in older individuals.

Conclusions:

  • Significant knowledge gaps persist in understanding and managing OAMS.
  • Holistic care approaches are essential, considering wellness and potential DMT cessation.
  • Further research is critical to ensure evidence-based, high-quality care for the growing OAMS population.

Related Concept Videos

Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
94
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
537
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
183
Aging01:26

Aging

Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
49
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.4K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
468